These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 13941824)

  • 1. Serum lipid levels and the severity of coronary and cerebral atherosclerosis in adequately-nourished men, 60-69 years of age.
    PATERSON JC; ARMSTRONG R; ARMSTRONG EC
    Med Serv J Can; 1963 Jun; 19():410-20. PubMed ID: 13941824
    [No Abstract]   [Full Text] [Related]  

  • 2. SERUM LIPID LEVELS AND THE SEVERITY OF CORONARY AND CEREBRAL ATHEROSCLEROSIS IN ADEQUATELY NOURISHED MEN, 60 TO 69 YEARS OF AGE.
    PATERSON JC; ARMSTRONG R; ARMSTRONG EC
    Circulation; 1963 Feb; 27():229-36. PubMed ID: 14173490
    [No Abstract]   [Full Text] [Related]  

  • 3. The fatty acid composition of serum total lipids and lipid fractions in coronary heart disease and cerebral atherosclerosis.
    Abdel Hay A; Kramer M; Keller L; Retsagi G
    J Egypt Med Assoc; 1970; 53(5):309-20. PubMed ID: 5506287
    [No Abstract]   [Full Text] [Related]  

  • 4. Data concerning blood lipid levels in cerebral atherosclerosis.
    Sterman-Marinchescu C; Stefănescu E; Ciurea E; Roman E; Ciucă V; Ologeanu M
    Neurol Psychiatr (Bucur); 1976; 14(4):. PubMed ID: 191901
    [No Abstract]   [Full Text] [Related]  

  • 5. LIPID MOBILISING FACTOR OF THE HYPOPHYSIS AND SOME QUESTIONS CONCERNING THE REGULATION OF LIPID METABOLISM.
    LIPOVETSKII BM
    Cor Vasa; 1964; 6():231-9. PubMed ID: 14177022
    [No Abstract]   [Full Text] [Related]  

  • 6. Current thought on serum lipids, atherosclerosis and coronary artery disease.
    DUFFY BJ; TURNER DA
    Bull Georgetown Univ Med Cent; 1955 Nov; 9(2):56-9. PubMed ID: 13269990
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes of blood lipid fractions produced by phosphatidyl choline in patients with atherosclerosis].
    Caruzzo C; Enrico-Bena L; Carnaghi R
    Minerva Med; 1969 Apr; 60(34):1643-52. PubMed ID: 5770941
    [No Abstract]   [Full Text] [Related]  

  • 8. [USE OF A SYNTHETIC HEPARINOID: CB 8061. CONSIDERATIONS ON 50 CASES AFTER 10 MONTHS OF CLINICAL AND BIOLOGICAL TRIALS].
    MANS J; GENES M
    J Med Bord; 1963 Dec; 140():1886-93. PubMed ID: 14099058
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain.
    Heinrich J; Schulte H; Schönfeld R; Köhler E; Assmann G
    Thromb Haemost; 1995 Mar; 73(3):374-9. PubMed ID: 7667818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipid free-radical oxidation in cerebral arteriosclerosis patients in relation to the stage of the disease].
    Bobyreva LE; Del'va VA; Samarchenko LA; Bobyrev VN; Voskresenskiĭ ON
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(9):1309-12. PubMed ID: 3425071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COMPARATIVE HISTOCHEMICAL STUDY OF HUMAN AND EXPERIMENTAL ATHEROGENSIS.
    GONZALEZ IE
    Ann Histochim; 1963; 8():335-8. PubMed ID: 14169858
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of Halidor on serum lipid fractions in patients with coronary disease and cerebrovascular sclerosis].
    Krámer M; Keller L; Molnár G
    Orv Hetil; 1968 May; 109(21):Suppl:42-3. PubMed ID: 5720723
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mental disorders caused by cerebral atherosclerosis and serum lipids].
    VALLET R; DUBUISSON J; BOMBART D
    Presse Med (1893); 1963 Apr; 71():911-4. PubMed ID: 13995926
    [No Abstract]   [Full Text] [Related]  

  • 14. [Relations between the degree of arteriosclerosis and trace element and lipid parameters].
    Voigt H; Reuter W; Peters HJ; Köhler H; Herrmann W
    Z Gesamte Hyg; 1984 Jun; 30(6):321-2. PubMed ID: 6475156
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study of blood lipids in coronary sclerosis and cerebrosclerosis].
    Keller L; Fischer J; Farádi A
    Orv Hetil; 1974 Jun; 115(23):1323-7. PubMed ID: 4840692
    [No Abstract]   [Full Text] [Related]  

  • 16. Laboratory parameters as discriminators for peripheral atherosclerosis and stroke.
    Kostner GM; Marth E; Pfeiffer KH; Wege H
    Monogr Atheroscler; 1986; 14():119-23. PubMed ID: 3736549
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes induced by D-thyroxine treatment in blood lipid indices in arteriosclerotic subjects].
    Notarbartolo A; Di Fede G; Cupidi G; Rini GB
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):979-83. PubMed ID: 4463989
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation of the extent and severity of atherosclerosis in the coronary and cerebral arteries.
    MATHUR KS; KASHYAP SK; KUMAR V
    Circulation; 1963 May; 27():929-34. PubMed ID: 13933662
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum lipid pattern changes and erythrocyte lipid content changes in patients with cerebral atherosclerosis.
    Maciejek Z; Madry K; Chmielewski H
    Acta Med Pol; 1979; 20(3):281-92. PubMed ID: 517166
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of diet treatment on the serum lipid level in patients with clinical symptoms of cerebral arteriosclerosis].
    ECKERSTROM S; SVENNERHOLM L
    Sven Lakartidn; 1961 Nov; 58():3438-48. PubMed ID: 13889099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.